← Back to Clinical Trials
Recruiting NCT05367609
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
Trial Parameters
Condition PPAP
Sponsor Senthil Sadhasivam
Study Type INTERVENTIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 10 Years
Max Age 21 Years
Start Date 2022-09-20
Completion 2026-08
All Conditions
Interventions
Preoperative Genotyping
Brief Summary
The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.
Eligibility Criteria
Inclusion Criteria: * Children ages 10 to 21 * ASA physical status 1 to 3 * Undergoing Posterior-Lateral Spinal Fusion * Receives in-patient opioids * Prescribed opioids at discharge Exclusion Criteria: * Serious illness * Preoperative severe pain * Preoperative opioid use or misuse